Osborne Clarke advised the European investor Redalpine Venture Partners on the deal. LegalFly successfully completed a €2 million seed financing round led by Redalpine, together with Mehdi...
You must be a Standard 1 Year member to access this content.
Osborne Clarke advised OncoDNA on the fundraising. OncoDNA announced its Round C financing of €6.5 million. Both private (including Vesalius BioCapital III, Ackermans & van Haaren,...
You must be a Standard 1 Year member to access this content.
Osborne Clarke has advised Sunrise. Sunrise recently raised €17 million to support the roll out of their ground-breaking sleep research in Europe and the American market. Sunrise’s...
You must be a Standard 1 Year member to access this content.
Osborne Clarke has advised Bone Therapeutics on the deal. Bone Therapeutics acquired a majority stake in Medsenic. This combination of Bone Therapeutics and Medsenic has created...
You must be a Standard 1 Year member to access this content.
Osborne Clarke and Ogier advised Industrious on the deal. Industrious, the highest-rated flexible workplace company, acquired 100% of the share capital and voting rights of its...
You must be a Standard 1 Year member to access this content.
Osborne Clarke has assisted in the latest investment in Greenomy. Euroclear, a Belgium-based global provider of Financial Market Infrastructure (FMI) services, is the investor. The investment...
You must be a Standard 1 Year member to access this content.
Osborne Clarke has advised Interel on the deal. Interel, an award-winning pan-European public affairs consultancy, has been acquired by Dentons Global Advisors. Interel has offices in...
You must be a Standard 1 Year member to access this content.
Osborne Clarke advised Bone Therapeutics on the deal. Bone Therapeutics, the bone cell therapy company addressing high unmet medical needs in orthopaedics and bone diseases, received...
You must be a Standard 1 Year member to access this content.
